Clinical Trial Update: Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA) [Phase 2, Phase 3]

View source ↗

Summary

Japanese rheumatoid arthritis trial evaluating CDP870 as add-on to methotrexate has completed (Phase 2/Phase 3) with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CDP870 (certolizumab pegol)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-08-06